Literature DB >> 10856134

Tissue remodeling as a feature of persistent asthma.

A M Vignola1, J Kips, J Bousquet.   

Abstract

A chronic inflammatory process is almost invariably associated with tissue damage and healing. Healing results in repair and replacement of dead or damaged cells by viable cells. Repair usually involves 2 distinct processes: regeneration, which is the replacement of injured tissue by parenchymal cells of the same type, and replacement by connective tissue and its eventual maturation into scar tissue. In many instances both processes contribute to the healing response. Chronic inflammatory disease can therefore lead to a wide variety of consequences, from complete or partial restitution of organ structure and function to fibrosis. Asthma is characterized by a chronic inflammatory process of the airways. The ensuing healing process results in structural alterations referred to as a remodeling of the airways. The mechanisms underlying these structural alterations are still largely unknown. They are likely to be heterogeneous, leading-through the highly dynamic process of cell de-differentiation, migration, differentiation, and maturation-to changes in connective tissue deposition and to the altered restitution of airways structure, resulting in mucus gland hyperplasia, neovascularization, fibrosis, and an increase in smooth muscle mass.

Entities:  

Mesh:

Year:  2000        PMID: 10856134     DOI: 10.1067/mai.2000.107195

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  44 in total

Review 1.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  A review of accelerated wound healing approaches: biomaterial- assisted tissue remodeling.

Authors:  Shirin Nour; Nafiseh Baheiraei; Rana Imani; Mohammad Khodaei; Akram Alizadeh; Navid Rabiee; S Mohammad Moazzeni
Journal:  J Mater Sci Mater Med       Date:  2019-10-19       Impact factor: 3.896

Review 4.  Pathogenesis of allergic airway inflammation.

Authors:  Devendra K Agrawal; Zhifei Shao
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

5.  Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure.

Authors:  Toshiyuki Koya; Taku Kodama; Katsuyuki Takeda; Nobuaki Miyahara; Eun-Seok Yang; Christian Taube; Anthony Joetham; Jung-Won Park; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

6.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up.

Authors:  J M Vonk; H Jongepier; C I M Panhuysen; J P Schouten; E R Bleecker; D S Postma
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

7.  Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation.

Authors:  Sarita Sehra; Weiguo Yao; Evelyn T Nguyen; Ayele-Nati N Ahyi; Florencia M Barbé Tuana; Shawn K Ahlfeld; Paige Snider; Robert S Tepper; Irina Petrache; Simon J Conway; Mark H Kaplan
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

8.  Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Authors:  Amy M Sutcliffe; Deborah L Clarke; Dawn A Bradbury; Lisa M Corbett; Jamie A Patel; Alan J Knox
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

9.  Icariin alleviates transforming growth factor-β1-induced epithelial-mesenchymal transition by targeting Smad and MAPK signaling pathways.

Authors:  Zhuying Li; Xingxing Yuan; Bingyu Wang; Fengli Gao
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  Flt3-ligand plasmid prevents the development of pathophysiological features of chronic asthma in a mouse model.

Authors:  Jehad H Edwan; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.